Emi Gal
About Emi Gal
Emi Gal is the Founder and CEO/CTO of Ezra, a company specializing in cancer detection services available in several major US cities. With a background in software engineering and entrepreneurship, he has over 15 years of experience in building successful technology companies.
Work at Ezra
Emi Gal serves as the Founder and CEO of Ezra, a company specializing in cancer detection services. Under his leadership, Ezra has expanded its services to multiple major cities across the United States, including New York, New Jersey, San Francisco, Los Angeles, Irvine, Miami, and Las Vegas. In June 2022, he took on the role of Chief Technology Officer, overseeing the AI and Platform engineering teams. His focus on technology and innovation drives the company's mission to enhance cancer detection and improve patient outcomes.
Education and Expertise
Emi Gal studied at Universitatea „Spiru Haret” din București, where he earned a Bachelor's Degree in Computer Science and Applied Mathematics from 2004 to 2008. His educational background laid the foundation for his extensive career in technology and entrepreneurship. With over 15 years of experience, he has developed expertise in software engineering, machine learning, and building successful technology companies.
Background
Originally from Romania, Emi Gal has a strong passion for coding. He often engages in software and machine learning projects during weekends, reflecting his commitment to technology and innovation. His career began with the founding of Brainient, an advertising technology company, which he led for a decade before its acquisition by Teads. He later served as CEO of Teads Studio, where he played a significant role in scaling the company to $1 billion in annual revenue.
Achievements
Emi Gal has a proven track record of success in the technology sector. He founded Brainient, which was acquired by Teads, demonstrating his ability to build and grow technology companies. As CEO of Teads Studio, he contributed to the company's significant revenue growth, helping it reach $1 billion in annual revenue. His leadership at Ezra continues to focus on advancing cancer detection technology, showcasing his commitment to health and longevity.